What Does Synthekine Do?

Total employees130
HeadquartersSouth San Francisco
Founded2018

Synthekine is an engineered cytokine therapeutics company dedicated to developing transformative medicines for cancer and autoimmune diseases. By leveraging their expertise in protein engineering and immunology, Synthekine designs and creates cytokine-based therapies that are precisely targeted to specific immune cell subsets. This approach aims to maximize therapeutic benefit while minimizing the off-target toxicities often associated with conventional cytokine treatments. Their pipeline includes innovative candidates designed to modulate the immune system with high selectivity and potency, offering new hope for patients with unmet medical needs.

Where Is Synthekine's Headquarters?

Synthekine officeSynthekine officeSynthekine officeSynthekine office
*Images sourced via web search. Rights belong to original owners

HQ Function

The headquarters serves as the central hub for Synthekine's research and development, laboratory operations, clinical development, corporate administration, and strategic planning.

Notable Features:

The facility likely houses state-of-the-art laboratories for protein engineering, cell biology, immunology research, and process development, designed to foster collaboration and innovation.

Work Culture:

As a research-driven biotech company, the work culture is expected to be innovative, collaborative, scientifically rigorous, and fast-paced, with a strong emphasis on translational science and patient impact.

HQ Significance:

Located in a prominent biotechnology cluster, the South San Francisco headquarters provides access to a rich ecosystem of talent, research institutions, collaborators, and venture capital, crucial for a company in the life sciences sector.

Values Reflected in HQ: The headquarters likely reflects Synthekine's commitment to cutting-edge science, innovation, precision, and a focused approach to drug development.

Location:

Currently, Synthekine's operational presence is primarily concentrated in the United States, with its research, development, and corporate functions based in South San Francisco. Their global reach is mainly through scientific collaborations, participation in international conferences, and potentially future clinical trial sites as their programs advance. They may engage with international partners for specific research or manufacturing activities.

Street Address:

1618 Station Pkwy NW

City:

South San Francisco

State/Province:

CA

Country:

USA

Where Else Does Synthekine Operate Around the World?

South San Francisco, CA/USA

Address: 1618 Station Pkwy NW, South San Francisco, CA 94080

Serves as the nerve center for all company activities, leveraging the Bay Area's rich biotech ecosystem.

Buying Intent Signals for Synthekine

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Synthekine? Meet the Executive Team

As of April 2025, Synthekine' leadership includes:

Debanjan Ray, Ph.D. - Chief Executive Officer & Co-Founder
Martin Giedlin, Ph.D. - Chief Scientific Officer & Co-Founder
Naiyer Rizvi, M.D. - Chief Medical Officer
Stephen E. Abel - Chief Business Officer
William Ho, J.D., Ph.D. - General Counsel
Andy Ramelmeier, Ph.D. - Chief Technology Officer
Pablo Cagnoni, M.D. - Executive Chairman

Who's Investing in Synthekine?

Synthekine has been backed by several prominent investors over the years, including:

The Column Group
Samsara BioCapital
RA Capital Management
Deerfield Management
Fidelity Management & Research Company
Franklin Templeton
GV (Google Ventures)
Emerson Collective
Lighthouse Capital Partners

What Leadership Changes Has Synthekine Seen Recently?

Hire1
Exits0

Synthekine has made key appointments to strengthen its leadership team over the past year, notably adding a Chief Business Officer. No significant high-profile executive departures have been publicly announced in this period.

New Appointments:

Stephen E. Abel, Stephen E. Abel joined Synthekine as Chief Business Officer.

What Technology (Tech Stack) Is Used bySynthekine?

Discover the tools Synthekine uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Synthekine Email Formats and Examples

Synthekine likely utilizes common corporate email formats. Based on industry standards and executive team names, the most probable format is firstinitiallast@synthekine.com or first.last@synthekine.com.

flast@synthekine.com (e.g., jdoe@synthekine.com) or first.last@synthekine.com (e.g. jane.doe@synthekine.com)

Format

dray@synthekine.com

Example

80%

Success rate

What's the Latest News About Synthekine?

Synthekine Press ReleaseNovember 6, 2023

Synthekine Presents Preclinical Data on STK-009 (pegylated IL-2 partial agonist) and Survodutide in Combination at AASLD The Liver Meeting® 2023

Synthekine presented promising preclinical data for STK-009 in combination with survodutide, showing potential benefits in treating metabolic dysfunction-associated steatohepatitis (MASH)....more

Synthekine Press ReleaseOctober 2, 2023

Synthekine Appoints Stephen E. Abel as Chief Business Officer

Synthekine announced the appointment of Stephen E. Abel as its Chief Business Officer, bringing extensive experience in biotech business development and corporate strategy....more

Synthekine Press ReleaseJune 5, 2023

Synthekine Appoints Naiyer Rizvi, M.D., as Chief Medical Officer

Dr. Naiyer Rizvi, a renowned oncologist and immunotherapy expert, was appointed as Synthekine's Chief Medical Officer to lead the company's clinical development strategy and operations....more

Synthekine Press ReleaseMay 1, 2023

Synthekine Announces $100 Million Series C Financing and Appointment of Pablo Cagnoni, M.D. as Executive Chairman

Synthekine secured $100 million in a Series C financing round, co-led by new and existing investors, to advance its pipeline of engineered cytokine therapeutics. Pablo Cagnoni, M.D., was also appointed as Executive Chairman of the Board....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Synthekine, are just a search away.